Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The central hypothesis is that lutein supplementation will improve MPOD and cognition. Accordingly, the specific aims are to 1) to determine the process feasibility associated with participating in 4-month lutein supplementation trial; and 2) to investigate the scientific feasibility of 4-month daily lutein supplementation on biological markers of lutein status and cognitive function among persons with MS.
Epistemonikos ID: 58b6d920db200794dee363a807489a640353bc0e
First added on: Mar 31, 2022